Cytek Biosciences, Inc.

CTKBNASDAQHealthcare● Active

$4.03

$-0.07(-1.59%)

Market Cap$519798913

P/E Ratio—

52W High$6.18

52W Low$2.9

Avg Volume794K

Open$4.12

Beta1.19

Cash on Hand Financials Revenue

Cytek Biosciences, Inc. (CTKB) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CTKB · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$261.5M▼ -5.9% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$90.9M

cashAndCashEquivalents

Short-Term Investments

$170.7M

shortTermInvestments

YoY Change vs Prior Year

-5.9%

vs prior fiscal year

Latest Quarter

$262.2M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$261.5MCash on Hand

Total Debt$23.7MTotal Debt

Net Cash / Net Debt+$237.8MNet Cash Position

Cash vs Debt Ratio

Cash 92%Cytek Biosciences, Inc. cash as % of market cap: 50.31%% · MCap $1BDebt 8%

Cytek Biosciences, Inc. has a net cash position of $237.8M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$261.5M − $23.7M = +$237.8M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

CTKB annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

CTKB cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$261.5M-5.9%

Dec 31, 2024FY$277.9M+5.9%

Dec 31, 2023FY$262.4M-23.1%

Dec 31, 2022FY$341.1M-6.4%

Dec 31, 2021FY$364.6M+120.7%

CTKB cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

CTKB vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Cytek Biosciences, Inc.YOU

CTKB

$261.5M$520M50.3%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Cytek Biosciences, Inc. (CTKB) cash on hand as of December 31, 2025 is $261.5M, comprising $90.9M in cash and cash equivalents (CCE) plus $170.7M in short-term investments — reported as Cytek Biosciences, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Cytek Biosciences, Inc. cash reserves or cash position.

Cytek Biosciences, Inc. annual cash on hand history shows decreased -5.9% in 2025: decreased -5.9% in 2025. Cytek Biosciences, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Cytek Biosciences, Inc. carries total debt of $23.7M against cash of $261.5M, resulting in a net cash position of +$237.8M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

CTKB cash on hand · 5 questions

As of December 31, 2025, Cytek Biosciences, Inc. (CTKB) has $261,529,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $90,853,000 in cash and cash equivalents (CCE) plus $170,676,000 in short-term investments. Latest quarter (March 31, 2026): $262,225,000. Data sourced from the annual 10-K filing via FMP.

CTKB cash on handCTKB cash reservesCTKB cash 2025how much cash does CTKB have

▸ Source: FMP /balance-sheet-statement · US GAAP · Cytek Biosciences, Inc. · Cytek Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025